DSP: Digital Spatial Profiling. by Jinho Lee (587173)

Subjects:

Combined Morphological and IHC Data: Combined Morphological and Immunohistochemistry Data. by Jinho Lee (587173)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Ingenuity pathway analysis. by Wendy J. Bailey (14926392)

Subjects:

Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x). by Jinho Lee (587173)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Whole genome sequencing map of the intron 25-exon 26 transition of the murine <i>Tg</i> locus. by Wendy J. Bailey (14926392)

Subjects:

Genotype-based analysis of the LINE-1. by Wendy J. Bailey (14926392)

Subjects:

RNA analysis reveals a ~6-fold reduced coverage of exon 26 in the murine <i>Tg</i> gene. by Wendy J. Bailey (14926392)

Subjects:

Correlation of H-scores of AR and ER expression in the peripheral lobules {STT (r = 0.95) and the LTT groups (r = 0.90)}. by Jinho Lee (587173)

Subjects:

Body weight (BW) measurements. by Wendy J. Bailey (14926392)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Thyroid dysplasia in inbred C57BL/6NTac mice WT, HET or HOM for the LINE-1. by Wendy J. Bailey (14926392)

Subjects:

S2 File - LINE-1 transposition into murine <i>Thyroglobulin</i> results in congenital thyroid dysplasia by Wendy J. Bailey (14926392)

Subjects:

Time course thyroid phenotype progression by genotype. by Wendy J. Bailey (14926392)

Subjects:

Consensus sequence assembly of the LINE-1 in intron 25 of mouse <i>Tg</i>, derived from long-read sequencing. by Wendy J. Bailey (14926392)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Correlations for H-scores of AR and ER expression in the lactiferous ducts {STT (r = 0.99) and the LTT groups (r = 0.93)}. by Jinho Lee (587173)

Subjects: